Cargando…
Rebalancing polyamine levels to treat Snyder–Robinson syndrome
Snyder–Robinson syndrome (SRS) is a rare genetic disorder characterized by intellectual disability and delayed development beginning early in childhood. It was first described in a single family in 1969 as a sex‐linked disorder (Snyder & Robinson, 1969) and has since been only identified in less...
Autor principal: | Gilmour, Susan K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630864/ https://www.ncbi.nlm.nih.gov/pubmed/37712293 http://dx.doi.org/10.15252/emmm.202318506 |
Ejemplares similares
-
Polyamine Homeostasis in Snyder-Robinson Syndrome
por: Murray-Stewart, Tracy, et al.
Publicado: (2018) -
Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
por: Stewart, Tracy Murray, et al.
Publicado: (2023) -
Snyder-Robinson syndrome
por: Starks, Rachel, et al.
Publicado: (2018) -
Phenylbutyrate modulates polyamine acetylase and ameliorates Snyder-Robinson syndrome in a Drosophila model and patient cells
por: Tao, Xianzun, et al.
Publicado: (2022) -
Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a novel mouse model of Snyder-Robinson Syndrome
por: Akinyele, Oluwaseun, et al.
Publicado: (2023)